According to a market report by Lucintel, the future of the global cevimeline market looks promising with opportunities in the hospital, clinic, and retail pharmacy markets. The global cevimeline market is expected to grow with a CAGR of 4.3% from 2025 to 2031. The major drivers for this market are increasing prevalence of dry mouth conditions, the rising demand for effective treatments, and the growing awareness of cevimeline benefits.
A more
than 150-page report to understand trends, opportunity and forecast in global cevimeline
market to 2031 by type (NDA and ANDA), application (hospitals, clinics, and
retail pharmacies), and region (North America, Europe, Asia Pacific, and the
Rest of the World).
Lucintel
forecasts that, within the type category, ANDA is expected to witness higher
growth over the forecast period.
Within the
application category, retail pharmacy is expected to witness the highest
growth.
Download
sample by clicking on cevimeline market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Daiichi
Sankyo, Lupin, Aurobindo Pharma, Rubicon Research, Cosette Pharmaceuticals,
Hikma Pharmaceuticals, Bionpharma, Rising Pharma Holdings, Macleods
Pharmaceuticals, Bryant Ranch Prepack are the major suppliers in the cevimeline market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Fluvastatin Methyl Ester Market
No comments:
Post a Comment